[Leish-l] FW: PRO/AH/EDR> Leishmaniasis, cutaneous - Suriname

[jeffrey shaw]

From: ProMED-mail <promed at promed.isid.harvard.edu>

Date: 2011/7/30
Subject: PRO/AH/EDR> Leishmaniasis, cutaneous - Suriname
To: promed-ahead-edr at promedmail.org


LEISHMANIASIS, CUTANEOUS - SURINAME


***********************************

A ProMED-mail post

<http://www.promedmail.org>

ProMED-mail is a program of the

International Society for Infectious Diseases

<http://www.isid.org>



Date: Wed 27 Jul 2011

Source: Royal Tropical Institute [edited]

http://www.kit.nl/-/INS/67346/Royal-Tropical-Institute/KIT-Biomedical-Research--/Considerable-increase-in-leishmaniasis-in-Suriname






Considerable increase in leishmaniasis in Suriname

--------------------------------------------------

Recent research in Suriname shows a considerable increase in the

numbers of cases of the parasitic skin disease leishmaniasis, in

Suriname better known as 'Bosjaws' or 'Busi-yasi.'



Within the integrated research programme 'Leishmaniasis in Suriname,'

coordinated by the department Biomedical Research of the Royal

Tropical Institute (KIT) and funded by NOW-WOTRO, Surinam and Dutch

researchers are studying the biology, diagnosis and treatment of the

disease. Furthermore, health care seeking behaviour of patients is

being studied.



Accurate diagnosis

------------------

At a recent consortium meeting, which was also attended by the

Minister of Health of Surinam and other local stakeholders, it was

announced that the number of registered leishmaniasis cases in 2010

was doubled compared to previous years.



And possibly even more cases are present in the hinterland of Surinam

that is not well accessible. This increase emphasizes the need for

good diagnosis of the disease, as it may be confused with other skin

diseases. The media in Surinam have called for more attention for

leishmaniasis. This also applies for Dutch general practitioners who

may be confronted more and more with the disease through patients who

have contracted slow healing ulcers during their visit to the interior

in Surinam.



Treatment and prevention

------------------------

Researcher Henk Schallig from KIT Biomedical Research emphasized that

appropriate treatment of leishmaniasis is needed to prevent further

spread of the disease, and that less painful therapies should be

sought. At the moment, leishmaniasis is treated in Suriname by giving

3 injections 3 times around the ulcers. Particularly for children this

treatment is very painful. In addition, the consortium demonstrated

that possibly not all patients responded well to treatment. The reason

for this is currently being investigated.



--

Communicated by:

ProMED-mail

<promed at promedmail.org>



[A study 5 years ago states "Cutaneous leishmaniasis (CL) is a

widespread disease in Suriname caused by Leishmania Viannia

guyanensis. It is argued that other Leishmania species are also

responsible for CL and that the incidence is increasing" and "With

extrapolation of collected data, a detection rate was calculated of

5.32 to 6.13 CL patients per 1000 inhabitants for the hinterland and

0.64 to 0.74 patients per 1000 inhabitants for the whole country."

(van der Meide WF et al. Epidemiology of cutaneous leishmaniasis in

Suriname: a study performed in 2006. Am J Trop Med Hyg.

2008;79:192-7). It should be noted that an increased interest in CL in

Suriname may increase the number of registered cases.



HealthMap location: <http://healthmap.org/r/15Lc>. - Mod.EP]



[see also:

Leishmaniasis, cutaneous - Honduras (SC)        20110708.2073

Leishmaniasis, cutaneous - Saudi Arabia: (QS)   20110328.0973

Leishmaniasis, cutaneous - Israel       20110130.0362]

.................................................sb/ep/ejp/dk

*##########################################################*

************************************************************

ProMED-mail makes every effort to  verify  the reports  that

are  posted,  but  the  accuracy  and  completeness  of  the

information,   and  of  any  statements  or  opinions  based

thereon, are not guaranteed. The reader assumes all risks in

using information posted or archived by  ProMED-mail.   ISID

and  its  associated  service  providers  shall not be  held

responsible for errors or omissions or  held liable for  any

damages incurred as a result of use or reliance upon  posted

or archived material.

************************************************************

Donate to ProMED-mail. Details available at:

<http://www.isid.org/ProMEDMail_Donations.shtml>

************************************************************

Visit ProMED-mail's web site at <http://www.promedmail.org>.

Send all items for posting to: promed at promedmail.org (NOT to

an individual moderator).  If you do not give your full name

name and affiliation,  it may not be posted.  You may unsub-

scribe at  <http://www.isid.org/promedmail/subscribe.lasso>.

For  assistance  from   a   human   being,   send  mail  to:

<postmaster at promedmail.org>.

############################################################

############################################################


 		 	   		  
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lineu.icb.usp.br/pipermail/leish-l/attachments/20120410/1ab8d5bc/attachment.htm>